People with insulin resistance and type 2 diabetes are more likely to develop plaques in the brain associated with Alzheimer’s disease, researchers in Japan reported on Thursday.

WEDNESDAY, Aug. 25 (HealthDay News) — Two of the most common and dreaded illnesses in America may share a connection, with new research suggesting that having insulin resistance or type 2 diabetes raises your risk of developing the brain plaques associated with Alzheimer’s disease.

Pfizer Inc. , Johnson & Johnson , and a half dozen competitors are committed to a research strategy for Alzheimers disease that has resulted in a string of study failures, the most recent involving Eli Lilly & Co.

Caring for someone with Alzheimer’s or dementia can be a daunting task, even for the most experienced of professionals working with seniors daily in assisted living and memory care.

(PhysOrg.com) — Alzheimer’s disease isn’t just about twisted brain cells. It’s also about the blood vessels that feed those neurons.

Alzheimer’s disease isn’t just about twisted brain cells.

The Sioux Falls City Council on Monday approved plans for an assisted living center to help Alzheimer’s patients, despite concerns from a group of neighbors on the city’s south side. It’s the most recent instance of controversy as commercial development moves into residential areas on the far edges of Sioux Falls.

APOEe-4 gene carriers with Alzheimer’s disease have more memory problems; non-carriers troubled with attention, language and executive functionIn the most comprehensive study to date, neurologists have clearly identified significant differences in the ways that Alzheimer’s disease (AD) affects patients with and without the apolipoprotein E 4 gene (APOE 4), a known genetic risk factor for the …

( Prometheus Books ) As the Boomer generation ages, a staggering number of Alzheimer’s cases are expected to develop in the next 10-20 years. Without a current cure, and with effective treatment at least 10 years away, there is a pressing need for novel solutions to address the multifaceted issues surrounding this disease. “The Alzheimer’s Solution: How Today’s Care Is Failing Millions — and …

Although caffeine is the most widely consumed psychoactive drug worldwide, its potential beneficial effect for maintenance of proper brain functioning has only recently begun to be adequately appreciated. Substantial evidence from epidemiological studies and fundamental research in animal models suggests that caffeine may be protective against the cognitive decline seen in dementia and Alzheimer …

Although caffeine is the most widely consumed psychoactive drug worldwide, its potential beneficial effect for maintenance of proper brain functioning has only recently begun to be adequately appreciated.

Although caffeine is the most widely consumed psychoactive drug worldwide, its potential beneficial effect for maintenance of proper brain functioning has only recently begun to be adequately appreciated. Substantial evidence from epidemiological studies and fundamental research in animal models suggests that caffeine may be protective against the cognitive decline seen in dementia and Alzheimer …

Washington, May 14 : Catheter ablation, treatment of the most common heart rhythm disorder, significantly reduces the risk of stroke, mortality, Alzheimer’s disease and other forms of dementia, researchers have found.

A newly identified gene appears to increase a persons risk of developing late-onset Alzheimers disease, the most common type of Alzheimers disease.

According to the National Institute on Aging dementia disease , Alzheimer s disease is a progressive brain disorder that is the most common form of dementia.

Caring for an individual with Alzheimer s disease truly puts your lifestyle in perspective. Previously harmless behaviors or items in the household can now be a danger, so taking a second look at the home is a necessity.

Learn More About Alzheimer’s , the Most Common Type of Dementia.

Soccer-ball-shaped carbon nanoparticles may harbour the cure for Parkinson’s disease, Alzheimer ’s and even cancer, according to a new American research.

March 18 (Bloomberg) — One of the most eagerly anticipated studies of a drug for Alzheimer’s disease may not yield results until 2012, two years later than had been forecast.

March 18 (Bloomberg) — One of the most eagerly anticipated studies of a drug for Alzheimer’s disease may not yield results until 2012, two years later than had been forecast.